Forrest Innovations Ltd. Announces the Appointment of Dr. Ima Braga and Prof. Philippos Papathanos to Its Advisory Board

      

(ProNewsReport Editorial):- Vancouver, British Columbia Aug 23, 2021 (Issuewire.com) – Forrest Innovations Ltd. (“Forrest”) announced today the appointment of Dr. Ima Braga and Professor Philippos Papathanos to its Scientific Advisory Board. These appointments are expected to strengthen Forrest’s ability to accelerate its implementation of its Natural Vector Control (“NVC”) to prevent mosquito-transmitted disease and to enhance and broaden the ability of Forrest to expand into new market opportunities by developing additional disease prevention solutions. 

Dr. Ima Braga holds a Ph.D. in Parasitic Biology from the Oswaldo Cruz Foundation in Brazil. She is trained in epidemiology and is President of the Latin American Vector Control Network- Relcov. In addition, she is the Technical Advisor to the State Health Department of Minas Gerais in Brazil. Dr. Braga specializes in the control of dengue and malaria vectors, monitoring of vector resistance to insecticides, entomological surveillance, and evaluation of surveillance and control alternatives for Aedes aegypti.

Professor Philippos Papathanos heads the Insect Genetics Lab at the Department of Entomology of the Hebrew University in Israel. Over the last 12 years, Professor Papathanos has been at the forefront of developing genetic control technologies in Anopheles mosquitoes. His work includes the first introduction and testing of homing endonucleases into insects, and the first genetically encoded male sterility system. He combines principles of synthetic biology and computational genetics to build engineered alleles that result in beneficial new traits in insect species.

Forrest Innovations Ltd.

Forrest was founded in 2013 and is a private Israel-based biotechnology company focused on mosquito-borne disease eradication with expertise in medical entomology R&D and healthcare. Forrest’s proprietary technology, Natural Vector Control (NVC), is commercially approved. Forrest’s pilot and commercial projects in Brazil led to an order of magnitude reduction in Dengue fever in treated areas*. For more information on Forrest, please visit https://www.forrestinnovations.com/.

Dr. Braga said: Arboviruses transmitted by Aedes aegypti such as dengue, Zika, and chikungunya have a great impact on public health. To meet this challenge, we need new approaches. I am very happy to participate in the Scientific Advisory Board of Forrest Innovations and contribute so that the proposed technologies such as Natural Vector Control are implemented. 

Professor Papathanos added: Pushing the boundaries of traditional mosquito genetics and genomics has the potential to revolutionize the future of disease control and deliver new methods for their sustainable and cost-effective application. Acting in the Scientific Advisory Board of Forrest Innovations, which is spearheading new technologies for mosquito-borne disease control, I hope to contribute to the successful implementation of their technologies and its interaction with mosquito genetics.

Contact Information

For further information, please contact: 

Forrest Innovations Ltd.: Nitzan Paldi, CEO, +972544777111 [email protected]

Certain statements in this press release are forward-looking statements, which reflect the expectations of management and the members of the Company’s Scientific Advisory Board. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations, or intentions regarding the future. Such statements are subject to risks and uncertainties that may cause actual results, performance, or developments to differ materially from those contained in the statements, including risks related to factors beyond the control of the Parties. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Parties will obtain from them.

*Additional information can also be found via the links below:

https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiab049/6122549

https://www.linkedin.com/in/ima-braga-09a605150/

https://www.linkedin.com/in/philippos-a-papathanos-978b2355/

 

(ProNewsReport Editorial):- Vancouver, British Columbia Aug 23, 2021 (Issuewire.com) – Forrest Innovations Ltd. (“Forrest”) announced today the appointment of Dr. Ima Braga and Professor Philippos Papathanos to its Scientific Advisory Board. These appointments are expected to strengthen Forrest’s ability to accelerate its implementation of its Natural Vector Control (“NVC”) to prevent mosquito-transmitted disease and to enhance and broaden the ability of Forrest to expand into new market opportunities by developing additional disease prevention solutions. 

Dr. Ima Braga holds a Ph.D. in Parasitic Biology from the Oswaldo Cruz Foundation in Brazil. She is trained in epidemiology and is President of the Latin American Vector Control Network- Relcov. In addition, she is the Technical Advisor to the State Health Department of Minas Gerais in Brazil. Dr. Braga specializes in the control of dengue and malaria vectors, monitoring of vector resistance to insecticides, entomological surveillance, and evaluation of surveillance and control alternatives for Aedes aegypti.

Professor Philippos Papathanos heads the Insect Genetics Lab at the Department of Entomology of the Hebrew University in Israel. Over the last 12 years, Professor Papathanos has been at the forefront of developing genetic control technologies in Anopheles mosquitoes. His work includes the first introduction and testing of homing endonucleases into insects, and the first genetically encoded male sterility system. He combines principles of synthetic biology and computational genetics to build engineered alleles that result in beneficial new traits in insect species.

Forrest Innovations Ltd.

Forrest was founded in 2013 and is a private Israel-based biotechnology company focused on mosquito-borne disease eradication with expertise in medical entomology R&D and healthcare. Forrest’s proprietary technology, Natural Vector Control (NVC), is commercially approved. Forrest’s pilot and commercial projects in Brazil led to an order of magnitude reduction in Dengue fever in treated areas*. For more information on Forrest, please visit https://www.forrestinnovations.com/.

Dr. Braga said: Arboviruses transmitted by Aedes aegypti such as dengue, Zika, and chikungunya have a great impact on public health. To meet this challenge, we need new approaches. I am very happy to participate in the Scientific Advisory Board of Forrest Innovations and contribute so that the proposed technologies such as Natural Vector Control are implemented. 

Professor Papathanos added: Pushing the boundaries of traditional mosquito genetics and genomics has the potential to revolutionize the future of disease control and deliver new methods for their sustainable and cost-effective application. Acting in the Scientific Advisory Board of Forrest Innovations, which is spearheading new technologies for mosquito-borne disease control, I hope to contribute to the successful implementation of their technologies and its interaction with mosquito genetics.

Contact Information

For further information, please contact: 

Forrest Innovations Ltd.: Nitzan Paldi, CEO, +972544777111 [email protected]

Certain statements in this press release are forward-looking statements, which reflect the expectations of management and the members of the Company’s Scientific Advisory Board. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations, or intentions regarding the future. Such statements are subject to risks and uncertainties that may cause actual results, performance, or developments to differ materially from those contained in the statements, including risks related to factors beyond the control of the Parties. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Parties will obtain from them.

*Additional information can also be found via the links below:

https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiab049/6122549

https://www.linkedin.com/in/ima-braga-09a605150/

https://www.linkedin.com/in/philippos-a-papathanos-978b2355/

 

Media Contact
GoPublic.AI
[email protected]
(778) 655-9134
475 Howe Street, Vancouver, BC, V6C 2B3
https://www.gopublic.ai/

GoPublic.AI
GoPublic.AI connects TSXv & CSE financiers, brokers, and dealmakers with shells & vetted, high-potential private companies wanting to go-public.
[email protected]
1 E Cordova St Unit 517

V6A 4H3
7789520418
https://www.gopublic.ai/

Source :https://www.forrestinnovations.com/

This article was originally published by IssueWire. Read the original article here.



More on the Pronewsreport: